Basics Passage Bio, Inc. IPO Date: February 28, 2020 Sector: Healthcare Industry: Biotech Market Cap: $29.28M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 4.22% Avg Daily Range (30 D): $0.42 | 5.34% Avg Daily Range (90 D): $0.30 | 4.07% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): .03M Avg Daily Volume (90 D): .03M Trade Size Avg Trade Size (Sh.): 137 Avg Trade Size (Sh.) (30 D): 73 Avg Trade Size (Sh.) (90 D): 82 Institutional Trades Total Inst.Trades: 245 Avg Inst. Trade: $1.96M Avg Inst. Trade (30 D): $1.33M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.49M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 162.16K     News Oct 17, 2025 @ 1:00 PM Sandhoff Disease Treatment Market Size Projects US... Source: Towards Healthcare Mar 4, 2025 @ 3:55 PM 2025 Market Prospects of Adeno-Associated Virus Ve... Source: Researchandmarkets.Com Feb 26, 2025 @ 12:00 PM Passage Bio to Participate in Upcoming Investor Co... Source: N/A Nov 6, 2024 @ 12:00 PM Passage Bio to Present at Guggenheim Securities He... Source: N/A Aug 30, 2024 @ 11:00 AM Passage Bio to Present at H.C. Wainwright 26th Ann... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $5.71 $-2.44 $-2.96 Diluted EPS $5.71 $-2.44 $-2.96 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -45.26M $ -7.75M $ -9.39M Operating Income / Loss $ -49.72M $ -8.66M $ -10.33M Cost of Revenue $ $ $ Net Cash Flow $ 20.48M $ -4.85M $ 20.05M PE Ratio 1.71     Splits Jul 14, 2025:   1:20 Jun 01, 2004:   20:1